Clare, Linda, Kudlicka, Aleksandra, Oyebode, Jan R., Jones, Roy W., Bayer, Antony, Leroi, Iracema, Kopelman, Michael, James, Ian A., Culverwell, Alison, Pool, Jackie, Brand, Andrew, Henderson, Catherine ORCID: 0000-0003-4340-4702, Hoare, Zoe, Knapp, Martin ORCID: 0000-0003-1427-0215 and Woods, Bob (2019) Individual goal-oriented cognitive rehabilitation to improve everyday functioning for people with early-stage dementia: a multicentre randomised controlled trial (the GREAT trial). International Journal of Geriatric Psychiatry, 34 (5). pp. 709-721. ISSN 0885-6230
Text (International_Journal_of_Geriatric_Psychiatry)
- Published Version
Available under License Creative Commons Attribution Non-commercial. Download (504kB) |
Abstract
Objectives: To determine whether individual goal-oriented cognitive rehabilitation (CR) improves everyday functioning for people with mild-to-moderate dementia. Design and methods: Parallel group multicentre single-blind randomised controlled trial (RCT) comparing CR added to usual treatment (CR) with usual treatment alone (TAU) for people with an ICD-10 diagnosis of Alzheimer, vascular or mixed dementia, and mild-to-moderate cognitive impairment (Mini-Mental State Examination [MMSE] score ≥ 18), and with a family member willing to contribute. Participants allocated to CR received 10 weekly sessions over 3 months and four maintenance sessions over 6 months. Participants were followed up 3 and 9 months post randomisation by blinded researchers. The primary outcome was self-reported goal attainment at 3 months. Secondary outcomes at 3 and 9 months included informant-reported goal attainment, quality of life, mood, self-efficacy, and cognition and study partner stress and quality of life. Results: We randomised (1:1) 475 people with dementia; 445 (CR = 281) were included in the intention to treat analysis at 3 months and 426 (CR = 208) at 9 months. At 3 months, there were statistically significant large positive effects for participant-rated goal attainment (d = 0.97; 95% CI, 0.75-1.19), corroborated by informant ratings (d = 1.11; 95% CI, 0.89-1.34). These effects were maintained at 9 months for both participant (d = 0.94; 95% CI, 0.71-1.17) and informant (d = 0.96; 95% CI, 0.73-1.2) ratings. The observed gains related to goals directly targeted in the therapy. There were no significant differences in secondary outcomes. Conclusions: CR enables people with early-stage dementia to improve their everyday functioning in relation to individual goals targeted in the therapy.
Item Type: | Article |
---|---|
Additional Information: | © 2019 The Authors |
Divisions: | Care Policy and Evaluation Centre |
Subjects: | R Medicine > RZ Other systems of medicine |
Date Deposited: | 28 Mar 2019 00:13 |
Last Modified: | 14 Nov 2024 21:12 |
URI: | http://eprints.lse.ac.uk/id/eprint/100361 |
Actions (login required)
View Item |